Quarterly report · Q1

Period2023-01-01 → 2023-03-31
Filed2023-05-02
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥665.3bn2023-01-01 → 2023-03-31Cons.Revenue IFRS
Revenue¥2.66T2022-01-01 → 2022-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥581.5bn2022-01-01 → 2022-03-31Cons.Revenue IFRS
Operating income¥206.4bn2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Operating income¥178.4bn2022-01-01 → 2022-03-31Cons.Operating profit loss IFRS
Profit before tax¥183.1bn2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Profit before tax¥593.5bn2022-01-01 → 2022-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥174.7bn2022-01-01 → 2022-03-31Cons.Profit loss before tax IFRS
Net income (owners)¥144.7bn2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥442.7bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥124.1bn2022-01-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income¥145.2bn2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Net income¥444.2bn2022-01-01 → 2022-12-31Cons.Profit loss IFRS (5-year summary)
Net income¥124.6bn2022-01-01 → 2022-03-31Cons.Profit loss IFRS
Total assets¥6.35Tat 2023-03-31Cons.Assets IFRS
Total assets¥6.55Tat 2022-12-31Cons.Assets IFRS
Total assets¥5.75Tat 2022-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥2.76Tat 2023-03-31Cons.Liabilities IFRS
Total liabilities¥2.93Tat 2022-12-31Cons.Liabilities IFRS
Net assets / equity¥3.59Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥3.62Tat 2022-12-31Cons.Equity IFRS
Net assets / equity¥2.98Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥2.89Tat 2021-12-31dCons.Equity IFRS
Equity (owners)¥3.51Tat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥3.54Tat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥665.2bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥866.9bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥655.3bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥721.7bnat 2021-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥55.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥483.8bn2022-01-01 → 2022-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥39.0bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥41.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥101.8bn2022-01-01 → 2022-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥22.7bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥196.4bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥306.2bn2022-01-01 → 2022-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥116.8bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥81.522023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥249.452022-01-01 → 2022-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥69.942022-01-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (diluted)¥81.492023-01-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥249.362022-01-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥69.912022-01-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
Equity ratio55.3%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio54.1%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio50.6%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 68
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-01-01 → 2023-03-31¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-01-01 → 2023-03-31¥443m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-01-01 → 2023-03-31¥654m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-03-31−¥10.6bn
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥723m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2023-01-01 → 2023-03-31¥24.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-03-31¥6.9bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2023-01-01 → 2023-03-31¥35.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥8m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.4bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2023-01-01 → 2023-03-31¥1.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2023-01-01 → 2023-03-31¥604.4bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2023-01-01 → 2023-03-31¥604.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥61m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥225.1bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2023-01-01 → 2023-03-31¥208.8bn
—segment totalrevenue2023-01-01 → 2023-03-31¥664.9bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥664.8bn
—segment totalrevenue intersegment2023-01-01 → 2023-03-31¥69m
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥233.5bn
—segment totalsegment profit2023-01-01 → 2023-03-31¥217.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-01-01 → 2022-03-31¥1.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-01-01 → 2022-03-31¥611m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-01-01 → 2022-03-31¥1.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-03-31−¥7.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-03-31−¥7.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-01-01 → 2022-03-31−¥7.8bn
Reconciling Itemsreconcilingrevenue2022-01-01 → 2022-03-31−¥1.3bn
Reconciling Itemsreconcilingrevenue intersegment2022-01-01 → 2022-03-31−¥1.3bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥38m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥38m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-03-31−¥38m
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue2022-01-01 → 2022-03-31¥21.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentrevenue external2022-01-01 → 2022-03-31¥21.3bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-03-31¥4.6bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-03-31¥4.6bn
jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segmentsegment profit2022-01-01 → 2022-03-31¥4.6bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue2022-01-01 → 2022-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue external2022-01-01 → 2022-03-31¥35.7bn
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentrevenue intersegment2022-01-01 → 2022-03-31¥0
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2022-01-01 → 2022-03-31¥412m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2022-01-01 → 2022-03-31¥412m
jpcrp040300-q1r_E00492-000Processed Foodreportable segmentsegment profit2022-01-01 → 2022-03-31¥318m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue2022-01-01 → 2022-03-31¥524.0bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue external2022-01-01 → 2022-03-31¥523.9bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentrevenue intersegment2022-01-01 → 2022-03-31¥59m
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2022-01-01 → 2022-03-31¥197.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2022-01-01 → 2022-03-31¥197.3bn
jpcrp040300-q1r_E00492-000Tobaccoreportable segmentsegment profit2022-01-01 → 2022-03-31¥181.3bn
—segment totalrevenue2022-01-01 → 2022-03-31¥581.0bn
—segment totalrevenue external2022-01-01 → 2022-03-31¥580.9bn
—segment totalrevenue intersegment2022-01-01 → 2022-03-31¥59m
—segment totalsegment profit2022-01-01 → 2022-03-31¥202.3bn
—segment totalsegment profit2022-01-01 → 2022-03-31¥202.3bn
—segment totalsegment profit2022-01-01 → 2022-03-31¥186.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 843
ItemContextValueUnit
Number of issued shares as of fiscal year end issued shares total number of shares etcFilingDateInstant2000000000
Number of issued shares as of filing date issued shares total number of shares etcFilingDateInstant2000000000
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember225079800
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember1773829100
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember17738291
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember1091100
Number of shares issued shares voting rightsCurrentQuarterInstant2000000000
Number of voting rights issued shares voting rightsCurrentQuarterInstant17738291
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member225079800
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member225079800
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.1125
Number of shares held in own name treasury shares etcCurrentQuarterInstant225079800
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant225079800
Shareholding ratio treasury shares etcCurrentQuarterInstant0.1125
Cash and cash equivalents IFRSPrior1YearInstant866885000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant665152000000JPY
Trade and other receivables ca IFRSPrior1YearInstant477239000000JPY
Trade and other receivables ca IFRSCurrentQuarterInstant473832000000JPY
Inventories ca IFRSPrior1YearInstant691906000000JPY
Inventories ca IFRSCurrentQuarterInstant705160000000JPY
Other financial assets ca IFRSPrior1YearInstant37677000000JPY
Other financial assets ca IFRSCurrentQuarterInstant40226000000JPY
Other current assets ca IFRSPrior1YearInstant649181000000JPY
Other current assets ca IFRSCurrentQuarterInstant607279000000JPY
Current assets other than assets held for sale ca IFRSPrior1YearInstant2722889000000JPY
Current assets other than assets held for sale ca IFRSCurrentQuarterInstant2491649000000JPY
Assets held for sale IFRSPrior1YearInstant702000000JPY
Assets held for sale IFRSCurrentQuarterInstant2075000000JPY
Current assets IFRSPrior1YearInstant2723591000000JPY
Current assets IFRSCurrentQuarterInstant2493724000000JPY
Property plant and equipment IFRSPrior1YearInstant775957000000JPY
Property plant and equipment IFRSCurrentQuarterInstant775820000000JPY
Goodwill IFRSPrior1YearInstant2446063000000JPY
Goodwill IFRSCurrentQuarterInstant2480887000000JPY
Intangible assets IFRSPrior1YearInstant246442000000JPY
Intangible assets IFRSCurrentQuarterInstant236533000000JPY
Investment property IFRSPrior1YearInstant9495000000JPY
Investment property IFRSCurrentQuarterInstant9172000000JPY
Retirement benefit asset nca IFRSPrior1YearInstant57792000000JPY
Retirement benefit asset nca IFRSCurrentQuarterInstant60278000000JPY
Investments accounted for using equity method IFRSPrior1YearInstant56943000000JPY
Investments accounted for using equity method IFRSCurrentQuarterInstant53426000000JPY
Other financial assets nca IFRSPrior1YearInstant140366000000JPY
Other financial assets nca IFRSCurrentQuarterInstant145648000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-12-31pass
balance sheet identityconsolidated 2023-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass